http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Mode of Action, Clinical Aspects and New Drugs
Molecular Mechanisms of Anthracycline Activity -- Anthracycline Cardiotoxicity -- Daunomycin-TFO Conjugates for Downregulation of Gene Expression -- Acid-Sensitive Prodrugs of Doxorubicin -- Doxorubicin Conjugates for Selective Delivery to Tumors -- Anthracycline–Formaldehyde Conjugates and Their Targeted Prodrugs -- Sabarubicin -- Nemorubicin.